Press Releases

Study Shows Biocept’s Target Selector™ Detects Mutations in “Quantity Not Sufficient” Specimens in Non-Small Cell Lung Cancer Patients

Biocept presents data showing that its Target Selector™ molecular assay kit detects mutations in up to 50% of tissue biopsy specimens, from patients diagnosed with non-small cell lung cancer, that were deemed quantity not sufficient (QNS), at the Molecular Med Tri-Con Virtual Conference.

Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation

ObvioHealth Announces Next Generation Virtual Research Platform and Ecosystem

VivaLNK Offers Untethered Wearable ECG Monitor Solution for Six-Minute Walk Test

Captures ECG and heart rate as a response to treatment for heart, lung, and health problems

Profacgen Updated Its Service for Isothermal Titration Calorimetry

Whole Genome Sequencing for GutFlora Now Available by the GutFlora Omics Platform

The product manager of Creative Proteomics has recently announced the fully-developed whole-genome sequencing, which can work as a powerful tool in multiple areas including diagnosis, tracking disease outbreaks, characterizing causative mutations and identifying drug-resistance genes.

Pronalyse Division Supports Biopharma Research with Protein Homogeneity Analysis Service

Pronalyse, a new division of Creative Proteomics, is dedicated to providing professional analysis services in biopharmaceutical development. Creative Proteomics is an integrated CRO company with more than 10 years of experience in providing impurity analysis and analytical characterization service for bioprocess development. Recently, the product manager of Pronalyse division announced protein homogeneity analysis service to speed up the drug development process.

UK Healthcare Pavilion brings Together the UK’s Healthcare and Life Sciences Sector for The First Time

The UK Healthcare Pavilion has launched a new virtual platform to bring together life sciences companies, hospitals, clinics, and key organisations — helping global customers discover, connect and innovate.

CD BioSciences Announces to Provide Global Scientists with Early Phase Clinical Services

CD BioSciences, a US based supplier of clinical development services, has announced to provide global scientists with early phase clinical services, aiming to accelerate their drug development projects.

VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine

BOC Sciences Launched Its E3 Ubiquitin Ligase Activity Assay Services to Assist PROTAC Drug Development

Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service

Profacgen Provides an Ultimate Solution of Cell-free Protein Production

Lifeasible Developed Thermal Analysis Platform for Material Research

Matexcel Introduced Mechanical Environment Reliability Test Worldwide

Virus-like Particles (VLPs) for Various Applications Now Available at Creative Biostructure

ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the release of its ImmunoGenomiX (IGX) Platform featuring the new Antibody Discovery Module. The IGX Platform is a professional tool to manage, analyze, integrate, and visualize immune repertoire sequencing data in a single environment. This solution will allow scientists in biopharmaceutical companies and academia, as well as service providers working in the antibody discovery field, to make the most of their Sanger and NGS data and independently perform complex analyses.

Scytek Laboratories Inc Stain Nuclei Histology Red Special Stain,Histology,Nuclear Fast Red Solution,H E,Eosin

Scytek laboratories Inc offers Special Stains, Antibodies, Hematology, Microbiology, Hematoxlyn, Scytek Stain Nuclei Histology Red Special Stain, Histology, Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system

Immudex ApS, the sole proprietor of DNA barcoded MHC multimer technology, has announced the launch of dCODE Dextramer® (RiO) — a new reagent compatible with BD Rhapsody™ Single Cell Analysis system for multiplexing, allowing the identification of many different T-cell specificities in the same sample. Creating personalized dCODE Dextramer® libraries, is possible to profile T cells and get a new understanding of T-cell immunity.

eClinical Solutions Launches elluminate® Clinical Trial Management System (CTMS) for Faster Drug Development

The elluminate platform now automates clinical operations data workflows with focus on interoperability and analytics for outsourced development models